This firm appears in the Who's Who Legal 100 2014
Click on the name of a lawyer below to view their profile. Lawyers shaded in blue have professional biographies in one or more practice areas.
Click on an Office to view Lawyers in that location.
In the last year Kaye Scholer has made three new partner hires in corporate tax, structured finance and competition law; the firm has also made another 16 internal promotions, the largest group of lawyers to be elevated at the firm in five years.
|Corporate Governance||1||Private Funds||1|
|Information Technology||1||Product Liability Defence||6|
|Labour & Employment||1||Sports & Entertainment||1|
Kaye Scholer remains committed to litigation, particularly in the life sciences industries, in which it has accumulated decades of experience. Indeed, 83 of Kaye Scholer’s clients in this sector have been with the firm for 20 years or more, including Novartis, Pfizer and Citigroup. The firm has also looked to expand its litigation practice, and has recently established an energy and infrastructure industry group, and a food, beverage and supplements group, to respond to growing client demand.
|Total Listings in WWL||28||Established||1917|
|Home jurisdiction||US||Total size of firm||433|
|Number of partners||138||Number of offices||9|
PEOPLE AND PRACTICES
Kaye Scholer excels in our product liability defence and life sciences chapters. William Hoffman is one of a number of the firm’s partners nominated in both categories. He has a great deal of experience representing clients in product liability and other complex litigation, criminal investigations, regulatory matters and litigation avoidance counselling. Jay Mayesh has defended his clients against product liability claims for more than 40 years. He has represented many large pharmaceutical firms and other life sciences entities, including serving as trial counsel for Baxter Healthcare on breast implant litigation. Sheila Boston is a “key member” of Kaye Scholer’s product liability group; assessing litigation risks, defending against class actions and mass torts, and devising creative settlement solutions. She is highly valued by her clients for her “outstanding support” and “reliability”. Pamela Yates is particularly noteworthy for her skills in court, and is “highly valued” by pharmaceutical clients for her “incredible knowledge” of the industry. Gerald Sobel is an “excellent” lawyer in the field of patents and life sciences. He was the lead counsel in the longest biotech patent trial, on the behalf of Xoma against the patent infringement claim by Centocor.
Kaye Scholer also fields two very highly rated practitioners in the M&A chapter. Diane Holt Frankle represents public and private companies in a wide variety of US and cross-border mergers, acquisitions, change of control transactions, related party transactions, strategic alliances and joint ventures. She is lauded by her peers and clients alike for her “intelligence”, “insightfulness” and “unrivalled” knowledge of the M&A market. Joel Greenberg is the senior corporate partner and co-chair of the Canada group and is commended for his “intimate knowledge” of M&A law. This year he advised TMS International Corp in its acquisition by The Pritzker Organization for approximately $1 billion.
Further recognition goes to Saul Morgenstern for competition law. His expertise played a key role in obtaining the dismissal of a putative class action brought against Amazon.com and major publishers of electronic books.
The firm is extremely dedicated to the advancement of pro bono work and is a chartered member of the Law Firm Pro Bono Challenge, which requires that at least three percent of the overall practice contribute to pro bono work. This is often exceeded. One particular case of note was the positive result in the 11th Circuit after filing an amicus brief on behalf of Autism Speaks.
Kaye Scholer’s focus is on sustainable growth. In particular, it looks to place continued emphasis on those practices that are recognised by clients as outstanding, while extending this model to a few other core industries such as technology, consumer products, media and entertainment and energy and infrastructure.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.